Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Corrigendum
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letters to Editor
Literature Review
Nephrology in India
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Corrigendum
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letters to Editor
Literature Review
Nephrology in India
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
View/Download PDF

Translate this page into:

Letters to Editor
20 (
4
); 224-225

Authors’ reply

Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh-160 012, India

Address for correspondence: Dr. Vinay Sakhuja, Department of Nephrology, Postgraduate Institute of Medical Education & Research, Chandigarh-160 012, India. E-mail: vsakhuja@glide.net.in

Read LETTER associated with this -

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Disclaimer:
This article was originally published by Medknow Publications and was migrated to Scientific Scholar after the change of Publisher.

Sir,

We appreciate the keen interest[1] in our case report “Allograft and prostatic involvement in a renal transplant recipient with disseminated tuberculosis: a case report”[2] and very relevant issues raised. In this regard, we would like to bring to your attention that:

  1. The KDIGO clinical practice guidelines for the care of kidney transplant recipients[3] recommend susceptibility testing on all isolates of Mycobacterium tuberculosis from kidney transplant recipients because the recipients may belong to diverse geographic locations where the prevalence of drug resistance may vary. Identifying drug susceptibility is all the more important in transplant recipients in view of the limited drug options available for them due to significant interaction of rifamycins with calcinurin inhibitors (CNIs) and mTOR inhibitors. The current recommendation for treatment of tuberculosis in kidney transplant recipient is to use the same treatment regimen as used in local general population who require therapy.[3] Rifampicin may be substituted with rifabutin with close monitoring of CNI drug levels, or a fluoroquinolone may be used instead of rifamycins. The efficacy of rifamycin sparing regimen in kidney transplant recipients has been reported from our center in the past.[45] The duration of therapy has not been defined, but it may be prudent to consider the experience from rifampicin-free regimen used in general population, which in general are 9 months or more in duration.

  2. Aguado et al.[6] has reported that treatment duration less than 9 months was associated with greater mortality, and Park et al.[7] reported that the only factor that was significantly associated with greater recurrence of TB was duration of treatment: no recurrence was observed in patients who received more than 12 months treatment, irrespective of whether the treatment regimen included rifampicin. The Spanish Society of Infectious Disease and Clinical Microbiology recommends[8] duration of at least 12-18 months in solid organ transplant recipients.

  3. The prostatic abscess in our patient was asymptomatic and was picked up only on imaging; he had no evidence of bladder outlet obstruction. Hence, an intervention for draining the same was not considered necessary. A repeat CT scan after 3 months of antitubercular chemotherapy showed complete resolution of the abscess.

References

  1. , , , . Tuberculosis in renal transplant recipient. Indian J Nephrol in press
    [Google Scholar]
  2. , , , , , , . Allograft and prostatic involvement in a renal transplant recipient with disseminated tuberculosis. Indian J Nephrol. 2010;20:40-2.
    [Google Scholar]
  3. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant work group. The KDIGO clinical practice guidelines for the care of kidney transplant recipients. In: Am J Transplant. Vol 9. . p. :8.
    [Google Scholar]
  4. , , , , , . The high incidence of tuberculosis among renal transplant recipients in India. Transplantation. 1996;61:211-5.
    [Google Scholar]
  5. , , , , , , . Successful management of pulmonary tuberculosis in renal allograft recipients in a single center. Kidney Int. 1999;56:1944-50.
    [Google Scholar]
  6. , , , , , , , . Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplantation. 1997;63:1278-86.
    [Google Scholar]
  7. , , , , , , . Clinical outcomes of tuberculosis in renal transplant recipients. Yonsei Med J. 2004;45:865-72.
    [Google Scholar]
  8. , , , , , , . Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis. 2009;48:1276-84.
    [Google Scholar]

Fulltext Views
237

PDF downloads
265
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections